The country’s largest lender, State Bank of India (SBI), and 10 other global banks, have combined forces to finance one of ...

Sun Pharmaceutical Industries has lined up 11 banks, including State Bank of India (SBI), to finance its $11.75 billion ...

India's dealmaking landscape in the April-June quarter was dominated by a handful of blockbuster transactions, with Sun ...

Organon & Co. OGN said on Sunday it signed a definitive agreement to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion. According to the terms of the agreement, ...

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Organon & Co. (NYSE:OGN) is one of the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

India’s largest pharmaceutical company will acquire Jersey City-based drugmaker Organon & Co. in an all-cash deal valued at about $11.75 billion. Sun Pharma will buy Organon for $14 a share. The price ...

Sun Pharma's $11.75 billion Organon acquisition was much bigger than a typical pharma deal. Once people looked past the headline, the story became surprisingly interesting. The acquisition involved ...

The news: Mayne Pharma has appointed Meghan Rivera as a non-executive director, effective 26 June. The context: Rivera brings ...

Organon’s portfolio includes more than 70 products across women’s health and general medicines, including biosimilars. The transaction has been approved by the Boards of Directors of both Sun Pharma ...